UBC Named Preferred Oncology Research Partner
United BioSource Corp. has been named the preferred oncology research partner by RainTree Oncology Services Corp
United BioSource Corp. (UBC) has been named the preferred oncology research partner by RainTree Oncology Services Corp., a community oncology alliance. The alliance seeks to standardize research processes within the the RainTree community oncology setting, UBC will have access to patient data and will partner to administer prospective and retrospective observation studies, which will provide information about the safety and efficacy of medicine in daily clinical use. UBC is a subsidiary of Express Scripts.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025